Skip to Main Content
Looking back we've always looked forward

 

Safetac® - a soft-silicon contact layer which is a gentle adhesive. It provides less pain and damage to the skin during dressing changes. This Mölnlycke innovation is today a global standard within woundcare dressings.
Pressure Ulcer Prevention -  already in 2005, Mölnlycke pioneered this area with the usage of 5-layer sacral and heel dressings for preventing hospital-acquired pressure ulcers. Today we have clinical, scientific and health economic evidence to prove the dressings efficiency. 
Oxygen Therapy – entering a new field with the topical haemoglobin spray Granulox® for oxygenation of chronic wounds. 


Do you want a future with Mölnlycke?

Imagine a future where healthcare professionals are armed with smart, connected solutions that enable them to capture and deliver real-time data – and there is no conflict between wound assessment and undisturbed healing.

Imagine the benefits these solutions could bring to clinical decision-making and picture a future when products are supported by monitoring and smart alerts – powering prevention, treatment and compliance .  Think of the improved efficiency – the freeing up of resources and capacity.

This is a vision we are working towards. We want to channel technology to make this a reality and transform the way healthcare professionals are able to care for their patients.

Let's discuss the future of wound management together

GET IN TOUCH WITH US
Select market

Select market